Abstract:Objectives: General To delineate the epidemiological and clinical profile of elderly individuals diagnosed with dementia who use antidementia drugs and are followed up in the Unified Health System (SUS), comparing them with a group that does not undergo pharmacological treatment, as well as the sociodemographic characteristics of their respective caregivers. Specific 1. Compare sociodemographic (age, sex, education, marital status, region), clinical (comorbidities, stage of dementia, most common symptoms, dementia medication used, use of other psychotropics) characteristics and caregiver profile (education, age, mental illness, formality of care, caregiver burden) between the group of people receiving pharmacological treatment for dementia and the group, also diagnosed with dementia, but not using medication for it. 2. Test whether the geographic region is a modifying effect of the associations found in specific Objectives item 1. 3. Identify, among individuals using psychotropic drugs for dementia, the type of medication used and at what stage of the disease it was introduced and is being used, and how access to the medication was achieved— purchased or dispensed by the SUS pharmacy. Methods: This is a retrospective, cross-sectional, observational, case-control, and non- randomized study conducted in the five geopolitical regions of Brazil, including a total of 17 cities of different sizes (small, medium, and large). All 140 people interviewed and diagnosed with dementia, as well as their 140 respective caregivers, were included. The following manuals and scales were used for evaluation: the Clinical Dementia Rating (CDR) - a questionnaire for clinical assessment of dementia, the Neuropsychiatry Inventory-Questionnaire (NPI-Q) - used for assessing neuropsychiatric symptoms, the Johns Hopkins Dementia Care Needs Assessment (JHDCNA 2.0) - an instrument that assesses the care needs of people with dementia and their caregivers, the Montreal Cognitive Assessment (MoCA) - a cognitive screening instrument, and DEMQOL. Data will be grouped for analysis of grouped and cumulative frequency and correlations between variables established using Microsoft Excel software. Statistical data will be processed with the STARTA software. Results: The present study is under statistical analysis, with completion expected in June. The following hypotheses are intended to be investigated: 1. Patients using pharmacological treatment for dementia with more clinical comorbidities use more anticholinesterase drugs. 2. There is an association between the prescription of pharmacological treatment for dementia and the region of the country. 3. Patients taking anticholinesterase drugs exhibit fewer neuropsychiatric symptoms compared to the population not using such medication and classified at the same stage of dementia. 4. Caregivers of people with dementia using pharmacological treatment for it are less burdened than caregivers of the other group not using pharmacological treatment for it. Conclusions: The exponential increase in dementia cases, in light of the global aging population, underscores the importance of investigating the factors associated with the pharmacological treatment of elderly people with dementia—to mitigate the obstacles that hinder adequate treatment.

FC30: Bridging the gap: an estimate of undetected dementia in Brazil and differences between genders, age groups and regions

P34: Pharmacological Treatment Use for Dementia in the Elderly Population from the National Report on Dementia in Brazil (ReNaDe): Associated Aspects

Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians

Hospital admissions for dementia in the Brazilian public health system over the last decade

P31: Direct and indirect costs of dementia in Brazil

Prevalence of Dementia in Latin America, India, and China: a Population-Based Cross-Sectional Survey

Incidence of Mild Cognitive Impairment and Alzheimer Disease in Southern Brazil

Accessing Dementia Care in Brazil: An Analysis of Case Vignettes

Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: a 10/66 Population-Based Study.

How Many People Live with Dementia in Portugal? A Discussion Paper of National Estimates

Epidemiology of mild cognitive impairment in Brazil

FC29: Assessing physical activity's impact on dementia occurrence among older adults in Brazil: Evidence from the ELSI-Brazil Study

Knowledge and attitudes about dementia of primary care physicians in Southern Brazil

Alzheimer’s Disease and Other Dementias in China: Secular Trend in Disease Burden from 1990 to 2019 and Projections to 2030

Approximating dementia prevalence in population-based surveys of aging worldwide: An unsupervised machine learning approach

Prevalence of dementia diagnosis in Sweden by geographical region and sociodemographic subgroups: a nationwide observational study

Population attributable fractions for risk factors for dementia in seven Latin American countries: an analysis using cross-sectional survey data

Detecting Frailty in Elderly Type 2 Diabetes Mellitus (T2DM) Patients in the Southeast of Brazil

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers

Systematic review estimating the burden of dementia in the WHO Southeast Asia Region using Bayesian and frequentist approaches

"The Contribution of Chronic Diseases to the Prevalence of Dependence among Older People in Latin America, China and India: a 10/66 Dementia Research Group Population-Based Survey"